Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: JSB who wrote (6476)	5/24/1999 4:33:00 PM
From: Dale Baker	Read Replies (2) \| Respond to of 118717

Anything is possible when the market goes flat like this - up, down, sideways, white, black and purple. What do you think of SONE after their latest acquisitions?

To: JSB who wrote (6476)	5/24/1999 4:46:00 PM
From: Dale Baker	Read Replies (2) \| Respond to of 118717

We will see if this makes a difference to ENMD - I kinda doubt it since they are a cancer cure play. EntreMed Inc. (ENMD) 26 1/4 -13/16: developer of biopharmaceutical products posts a Q1 net of $0.55 a share, much wider than the First Call loss estimate of $0.24 a share, vs year-ago loss of $0.25 a share; total revenues rose 25% to $1.44 mln; see press release..... I know that later this year I will look back and chuckle at our current consternation from dropping back a fair amount, but I will need everyone's support to take this in stride for now. Eyes on the prize, eyes on the prize...